XVIVO.ST
Price:
$452
Market Cap:
$14.24B
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP....[Read more]
Industry
Medical - Devices
IPO Date
2012-10-08
Stock Exchange
STO
Ticker
XVIVO.ST
According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 68.48. This represents a change of -8.20% compared to the average of 74.60 of the last 4 quarters.
The mean historical PE Ratio of Xvivo Perfusion AB (publ) over the last ten years is 451.55. The current 68.48 PE Ratio has changed 1.42% with respect to the historical average. Over the past ten years (40 quarters), XVIVO.ST's PE Ratio was at its highest in in the September 2018 quarter at 9.87K. The PE Ratio was at its lowest in in the March 2017 quarter at -11577.46.
Average
451.55
Median
283.46
Minimum
-195.08
Maximum
1.32K
Discovering the peaks and valleys of Xvivo Perfusion AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 439.44%
Maximum Annual PE Ratio = 1.32K
Minimum Annual Increase = -605.16%
Minimum Annual PE Ratio = -195.08
Year | PE Ratio | Change |
---|---|---|
2023 | 107.42 | -63.36% |
2022 | 293.22 | -70.25% |
2021 | 985.47 | -605.16% |
2020 | -195.08 | -121.37% |
2019 | 912.77 | 233.49% |
2018 | 273.70 | -28.20% |
2017 | 381.20 | -71.19% |
2016 | 1.32K | 439.44% |
2015 | 245.27 | 30.15% |
2014 | 188.46 | 131.60% |
The current PE Ratio of Xvivo Perfusion AB (publ) (XVIVO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
462.04
5-year avg
420.76
10-year avg
451.55
Xvivo Perfusion AB (publ)’s PE Ratio is greater than Vitrolife AB (publ) (-8.66), greater than BioArctic AB (publ) (-149.78), greater than CellaVision AB (publ) (37.79), greater than Invisio AB (publ) (62.70), greater than Hexatronic Group AB (publ) (18.62),
Company | PE Ratio | Market cap |
---|---|---|
-8.66 | $32.93B | |
-149.78 | $13.17B | |
37.79 | $5.68B | |
62.70 | $12.51B | |
18.62 | $8.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Xvivo Perfusion AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Xvivo Perfusion AB (publ) (XVIVO.ST)?
What is the highest PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST)?
What is the 3-year average PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST)?
What is the 5-year average PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST)?
How does the current PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST) compare to its historical average?